BIIE Aims to Be a Global Immune Engineering Embassy

In the final segment of an interview with BioPharm International®, Stephen Wilson, PhD, CEO and executive director of the Botnar Institute of Immune Engineering (BIIE), discusses how Basel, Switerland's collaborative research culture supports BIIE's mission. He also outlines what success will look like for the institute over a 3-year horizon. BIIE is launching a new research facility in the Switzerland Innovation Park Main Campus, housed within the Basel Area Life Sciences Supercluster.

Dr Wilson notes that Basel's academic research community is characterized by close, quickly formed personal connections, which positions BIIE as a specialized immune engineering partner integrated into that existing ecosystem. He explains that BIIE's collaborations will span pure academic partnerships through local institutions and strategic partner Oxford, industry-adjacent preclinical and pre-regulatory services for advanced translational projects, and established global health organizations already based in the region, including the Swiss Tropical and Public Health Institute, otherwise known as Swiss TPH.

What will success look like for BIIE within a 3-year timeframe?

Dr Wilson describes BIIE's ambition to function as an "embassy" connecting technologies, ideas, and people from low- and middle-income countries and the Global South to the Basel ecosystem, supporting capacity building alongside the institute's core mission of improving children's health. Within 3 years, the institute expects to move beyond discussing potential partnerships in the abstract to executing specific projects tied to global clinical partners addressing defined pediatric health problems, he explains.

"What you'll see in just 3 years are specific projects linked to global clinical partners, where we're attacking a problem, a real pediatric health issue, and we have an idea as to how we're going to solve it," Dr Wilson asserts.

Dr Wilson also shares the hope that BIIE's early success will make the institute a magnet for global talent and ideas, with the central challenge beyond the 3-year mark becoming what more ambitious work the institute can pursue next.

Explore more in segment 1 and segment 2 of Dr Wilson’s interview.

About the speaker

Stephen Wilson, PhD, CEO, Botnar Institute of Immune Engineering

Dr Wilson leads the Botnar Institute of Immune Engineering’s mission to advance global child and adolescent health through breakthrough immune engineering research. The institute brings together expertise across immunology, bioengineering, computational biology and artificial intelligence, with a strong focus on translating scientific discovery into real-world solutions. Its research is designed from the outset with the needs of underserved populations in mind, particularly in low- and middle-income countries. An immunologist and biotechnology executive with more than 30 years of experience, Dr Wilson previously served as executive vice president and chief operating officer of the La Jolla Institute for Immunology. Based in Basel, Switzerland, he is helping establish BIIE as a key part of the Basel Area Life Sciences Supercluster, one of the world’s leading hubs for biomedical innovation and research.